Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 23 Jun 2026 for Revolution Medicines, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Frank Clyburn: trading record in brief
Frank Clyburn is a declared insider at 5 companies (senior executive); the most frequent names are Merck & Co., Inc., Cencora, Inc. and Revolution Medicines, Inc. We count 31 filings; the first trade dates from 25 February 2019 and the latest from 18 June 2026.
Every open-market trade on record is a sale: 2 sales worth €3.0M. Outside the open market, there are 16 share grants and 13 option exercises.
Most recently, on 23 June 2026, the filings show a share grant in Revolution Medicines, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Frank Clyburn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
1,191 sharesCommon StockSEC:0001610717-26-000285:0
557 shares@ US$359.2868.5% of flowCommon StockSEC:0001763963-26-000004:0
2,806 shares0Common StockSEC:0001610717-25-000267:0
789 sharesCommon StockSEC:0001140859-25-000053:0
368 shares@ US$234.27100.0% of flowCommon StockSEC:0001140859-24-000140:0
6,932 shares0Common StockSEC:0001610717-24-000416:0
1,324 shares0Common StockSEC:0001225208-24-003735:0
1,323 shares0Common StockSEC:0001225208-23-003149:0
2,358 shares@ US$88.0559.6% of flowCommon StockSEC:0001127602-21-028169:0
19,324 shares0Common StockSEC:0001127602-21-016201:0
1,906 shares@ US$75.9840.4% of flowCommon StockSEC:0001127602-21-015744:0
11 of 11 declarations
